The HER Pathway and Cancer
Dietmar Berger discusses the role of the HER2 receptor in metastatic breast cancer.
Our immunology program offers the experience needed to transform knowledge into practice
Scientific Research Board
An advisory group to the company around research and early development projects.
The RAS-RAF Pathway
Chris Bowden explains the RAS-RAF pathway, an important and evolving area of cancer research.
How We Work
Scientists know that the work they’re doing has a profound impact on people’s lives. In this video they talk about increasing the rate of success by turning failures into learning…
Meet our Scientists
Scientists are at the core of our business. Learn about what inspires them every day.
The Genentech Research and Early Development pipeline has more than 20 new molecular entities in clinical development.
Call for Grants
Genentech is actively seeking applications for Independent Research Projects.
From Our Labs
Genentech Cancer Genome Project scientists have identified ERBB3 somatic mutations in human cancers. Learn more and read our publication in Cancer Cell.
Genentech named FORTUNE Best Company
We're honored to earn a place on FORTUNE's "100 Best Companies to Work For" list for the 17th consecutive year.
Request for Research Materials
We support investigators in academia by supplying key reagents. Request proteins, antibodies, and cDNAs.
Array biopharma and Genentech's strategic alliance was voted Breakthrough Alliance of 2012. Partner with us.
Support for Scientific Projects
We provide funding for general research, translational research, and other development projects.